American Journal of Medical Genetics Part C-Seminars in Medical Geneti

Papers
(The median citation count of American Journal of Medical Genetics Part C-Seminars in Medical Geneti is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Beyond chromosome analysis: Additional genetic testing practice in a Down syndrome clinic67
Bone health in RASopathies52
Clinical trials for genetic diseases in Latin America45
C3 glomerulopathy: Understanding an ultra‐rare complement‐mediated renal disease38
Catatonia responsive to corticosteroids in a patient with an SCN2A variant35
Obstetrics and gynecology in Ehlers‐Danlos syndrome: A brief review and update32
Newborn screening research sponsored by the NIH: From diagnostic paradigms to precision therapeutics29
Endocrinological manifestations in RASopathies29
Unlocking the potential of the UK 100,000 Genomes Project—lessons learned from analysis of the “Congenital Malformations caused by Ciliopathies” cohort28
Health care satisfaction and medical literacy habits among caregivers of individuals with Down syndrome27
Frequency of carriers for rare recessive Mendelian diseases in a Brazilian cohort of 320 patients26
Cover Image, Volume 187, Number 4, December 202126
Down syndrome across the lifespan24
Everyone Is a Tomato: Metagnostic Narratives of Genetic Revelation24
A Genomic Analysis of Usher Syndrome: Population‐Scale Prevalence and Therapeutic Targets24
Neurodevelopmental and other psychiatric disorders in 22q11.2 deletion syndrome from childhood to adult age: Prospective longitudinal study of 100 individuals22
Table of Contents, Volume 196, Number 4, December 202421
Central nervous system involvement in individuals withRASopathies20
Evolution of Health Care in Turner Syndrome20
Proximal urea cycle defects are challenging to detect with newborn screening: Results of a prospective pilot study using post‐analytical tools19
18
My Journey With Arthrogryposis and Some of the People Who Made a Difference17
Retrospective review of the code status of individuals with Down syndrome during the COVID‐19 era16
Advances in assessment of hypermobility‐related disorders16
Publication schedule for 202316
Fascial thickness and stiffness in hypermobile Ehlers‐Danlos syndrome15
Caregivers' concerns and supports needed to care for adults with Down syndrome14
Co‐occurring conditions in Down syndrome: Findings from a clinical database14
Children with Down syndrome who experience developmental skill loss, characterization, and phenomenology: A case series14
14
Revisiting the Neuropsychological and Clinical Profile of Mosaic Turner Syndrome With a Ring X Chromosome13
Infantile epileptic spasms syndrome in children with cardiofaciocutanous syndrome: Clinical presentation and associations with genotype13
Newborn screening and the recommended uniform screening panel: Optimal submissions and suggested improvements based on an advocacy organization's decade‐long experience12
Genetic testing and glomerular hematuria—A nephrologist's perspective12
Correction to “Experiences With Offering Pro Bono Medical Genetics Services in the West Indies: Benefits to Patients, Physicians, and the Community”12
Adult experiences in Beckwith–Wiedemann syndrome11
Non‐Invasive Prenatal Testing by Cell‐Free DNA (cfNIPT) for Detecting Turner Syndrome With Mosaicism and Structural Variants—Prenatal Findings and Postnatal Outcomes11
Duchenne expert physician perspectives on Duchenne newborn screening and early Duchenne care11
Cover Image, Volume 190, Number 1, March 202211
Family Lore, a Variant of Uncertain Significance, and CADASIL11
Normal joint range of motion in children with Down syndrome11
A plot TWIST10
Cover Image, Volume 196, Number 1, March 202410
Whole‐genome sequencing holds the key to the success of gene‐targeted therapies10
Molecular characterization of mucopolysaccharidosis type IVA patients in the Andean region of Colombia10
In Utero Therapies, the Next Frontier10
Occurrence of mosaic Down syndrome and prevalence of co‐occurring conditions in Medicaid enrolled adults, 2016–201910
Table of Contents, Volume 199, Number 1, March 20259
Autism and mild epilepsy associated with a de novo missense pathogenic variant in the GTPase effector domain of DNM19
Cover Image, Volume 190, Number 3, September 20228
Disease mechanisms of monogenic congenital anomalies of the kidney and urinary tract8
Table of Contents, Volume 190, Number 2, June 20228
Initial description and evaluation of EDS ECHO: An international effort to improve care for people with the Ehlers‐Danlos syndromes and hypermobility spectrum disorders8
Cover Image, Volume 193, Number 1, March 20238
Repurposing With Purpose: Treatment of Bachmann–Bupp Syndrome With Eflornithine and Implications for Other Polyaminopathies7
Ophthalmologic and neuro‐ophthalmologic findings in children with Down syndrome7
Table of Contents, Volume 193, Number 1, March 20237
Parental Decision‐Making Following a Prenatal Diagnosis of Turner Syndrome: A Systematic Review7
Data sharing to advance gene‐targeted therapies in rare diseases7
Integration of EpiSign, facial phenotyping, and likelihood ratio interpretation of clinical abnormalities in the re‐classification of an ARID1B missense variant7
New prospectives on treatment opportunities in RASopathies7
Table of Contents, Volume 193, Number 4, December 20237
Monogenic focal segmental glomerulosclerosis: A conceptual framework for identification and management of a heterogeneous disease7
Publication schedule for 20217
Circles7
The National Institutes of Health INvestigation of Co‐occurring conditions across the Lifespan to Understand Down syndromE (INCLU6
Genesis and genetics of a miracle6
A case–control study of respiratory medication and co‐occurring gastrointestinal prescription burden among persons with Ehlers–Danlos syndromes6
Ode to Fiona: The Face of Fortitude in FBXL4 Deficiency6
5
5
Molecular diagnosis in a cohort of 114 patients with rare skeletal dysplasias5
Cover Image, Volume 199, Number 1, March 20255
Artificial intelligence and the impact on medical genetics5
Autosomal dominant tubulointerstitial kidney disease: A review5
Table of Contents, Volume 193, Number 3, September 20235
Systematic assessment of monogenic etiology in adult‐onset kidney stone formers undergoing urological intervention–evidence for genetic pretest probability4
Biallelic variants in CENPF causing a phenotype distinct from Strømme syndrome4
Urogynaecology and Ehlers–Danlos syndrome4
Investigations of an individual with a Marfanoid habitus, mild intellectual disability, and severe social anxiety identifies PCDHGA5 as a candidate neurodevelopmental disorder gene4
Pain in the Ehlers–Danlos syndromes: Mechanisms, models, and challenges4
Publication schedule for 20234
Invisible strings4
COL1A1 and COL1A2 variants in Ehlers‐Danlos syndrome phenotypes and COL1‐related overlap disorder4
Comment From the Guest Editors4
Cover Image, Volume 193, Number 3, September 20234
3
Role of primary cilia and Hedgehog signaling in craniofacial features of Ellis–van Creveld syndrome3
Newborn screening for Duchenne muscular dystrophy‐early detection and diagnostic algorithm for female carriers of Duchenne muscular dystrophy3
Publication schedule for 20223
Newborn screening for neurodevelopmental diseases: Are we there yet?3
Natural history of MRAS‐related Noonan syndrome: Evidence of mild adult‐onset left ventricular hypertrophy and neuropsychiatric features3
Development of webcam‐collected and artificial‐intelligence‐derived social and cognitive performance measures for neurodevelopmental genetic syndromes3
Pneumonia vaccine response in individuals with Down syndrome at three specialty clinics3
The heart in RASopathies3
Table of Contents, Volume 187, Number 2, June 20213
Introduction to special issue for kidney genetics3
Cover Image, Volume 190, Number 2, June 20223
Overlap between irritable bowel syndrome and hypermobileEhlers–Danlossyndrome: An unexplored clinical phenotype?3
3
OFD1: One gene, several disorders3
Molecular advances, clinical management, and treatment opportunities in RASopathies2
First a Provider, Now a Patient: Receiving a Devastating Diagnosis Through the Patient Portal2
Spreading the Word: Communicating Evidence‐Based Guidelines About Turner Syndrome to Patients, Parents, Providers, and Payors2
Cover Image, Volume 187, Number 2, June 20212
Application of facial analysis Technology in Clinical Genetics: Considerations for diverse populations2
2
Clinical overview on RASopathies2
Family adaptation in families of individuals with Down syndrome from 12 countries2
Applications of artificial intelligence in clinical laboratory genomics2
On stillness2
Why must the debate continue on Krabbe disease newborn screening?1
Patients withEhlers–Danlossyndrome on the diagnostic odyssey: Rethinking complexity and difficulty as a hero's journey1
Diagnostic experiences of Duchenne families and their preferences for newborn screening: A mixed‐methods study1
Oral manifestations of Ehlers‐Danlos syndromes1
Publication schedule for 20221
The power of patient‐led global collaboration1
1
Multiorgan manifestations of COL4A1 and COL4A2 variants and proposal for a clinical management protocol1
Different, Not Less1
Perspectives and Insights Into Phenylketonuria: Patient Narratives About the Early Years Following Newborn Screening1
Neurodevelopmental atypisms in the context of joint hypermobility, hypermobility spectrum disorders, andEhlers–Danlossyndromes1
Parent Narratives Provide Perspectives on the Experience of Care in Trisomy 181
Ehlers–Danlos syndromes, hypermobility spectrum disorders, and associated co‐morbidities: Reports from EDS ECHO1
Spectrum of white matter abnormalities associated with FOXC1‐related disorders in two unrelated cases1
Publication schedule for 20231
A review of economic issues for gene‐targeted therapies: Value, affordability, and access1
Practicalities (and real‐life experiences) of dementia in adults with Down syndrome1
Turner Syndrome and Psychosocial Interventions: Recommendations for Collaborative Communication Between Medical and School Teams1
Dysautonomia in the Ehlers–Danlos syndromes and hypermobility spectrum disorders—With a focus on the postural tachycardia syndrome1
Healthy transition: Roadmap for young adults with Down syndrome to adulthood1
High rate of dyspareunia and probable vulvodynia in Ehlers–Danlos syndromes and hypermobility spectrum disorders: An online survey1
0.14780211448669